Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Osteogenic Sarcoma

vancomycin has been researched along with Osteogenic Sarcoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayramli, E; Dağdeviren, S; Kankilic, B; Kilic, E; Korkusuz, F1
Iwata, C; Kimura, K; Matsushita, R; Miyamoto, K; Nomura, M; Shimada, I; Taga, S; Teramachi, H; Tsuciya, H; Wada, T1
Buttaro, MA; Piccaluga, F; Pusso, R1
Blum, R; Seymour, JF; Toner, G1

Other Studies

4 other study(ies) available for vancomycin and Osteogenic Sarcoma

ArticleYear
Vancomycin containing PLLA/β-TCP controls MRSA in vitro.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:11

    Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Cell Adhesion; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteosarcoma; Polyesters; Polymers; Staphylococcal Infections; Vancomycin

2011
Enhanced renal clearance of vancomycin in rats with carcinogen-induced osteosarcoma.
    Anticancer research, 2012, Volume: 32, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Carcinogens; Kidney; Models, Animal; Osteosarcoma; Rats; Vancomycin

2012
Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results.
    The Journal of bone and joint surgery. British volume, 2005, Volume: 87, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis; Arthroplasty, Replacement, Hip; Bone Transplantation; Female; Follow-Up Studies; Graft Survival; Hip Injuries; Humans; Male; Middle Aged; Osteonecrosis; Osteosarcoma; Prosthesis-Related Infections; Radiography; Retrospective Studies; Transplantation, Homologous; Vancomycin

2005
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Methotrexate; Osteosarcoma; Vancomycin

2002